Course Directors

Dr. Amit Chopra. MD, MBBS, is a Psychiatrist at Massachusetts General Hospital (MGH). Dr. Chopra completed his medical training at Sawai Man Singh College, Jaipur, India in 2003, followed by research and clinical training in UK at King’s College London and University College London between 2003-2007. Dr. Chopra completed his Adult Psychiatry Residency, Sleep Medicine Fellowship, and Deep Brain Stimulation Fellowship at Mayo Clinic, Rochester, Minnesota in between 2007-2013.  Dr. Chopra has served as a Medical Director for Center for Treatment-Resistant Depression and Center for Psychiatric Neuromodulation in addition to his role as a President of Pittsburgh Psychiatric Society prior to him joining MGH. Dr. Chopra has multiple areas of interests including mood disorders, sleep disorders, and brain stimulation interventions for psychiatric disorders.

David Mischoulon, MD, PhD is the Director of the Depression Clinical and Research Program (DCRP) at Massachusetts General Hospital (MGH), and the Joyce R. Tedlow Professor of Psychiatry at Harvard Medical School. Dr. Mischoulon graduated from the combined MD-PhD program at Boston University School of Medicine in 1994, and interned in medicine at Carney Hospital from 1994-1995. From 1995-1998 he completed his residency in adult psychiatry at MGH, and served as Chief Resident in Psychopharmacology. Dr. Mischoulon's research focuses on various areas of depression, including complementary and alternative medicine. He is also an accredited medical acupuncturist and has studied acupuncture as a treatment for depression

Speakers

Joan Camprodon, MD, MPH, PhD is Chief of the Division of Neuropsychiatry at Massachusetts General Hospital and an Associate Professor of Psychiatry at Harvard Medical School. Clinically, he is the founding director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in Psychiatry and Behavioral Neurology-Neuropsychiatry.

Paolo Cassano, MD, PhD  is a staff psychiatrist at the DCRP and at the Center for Anxiety and Traumatic Stress Disorders (CATSD), and is a part-time assistant professor at Harvard Medical School. He is the principal investigator of a clinical trial on near-infrared radiation for the treatment of depression. Dr. Cassano’s research interests include the treatment of anxiety and mood disorders with novel technologies, and cross-cultural psychiatry

Cristina Cusin, MD,  is the director and founder of the MGH Ketamine clinic for treatment-resistant depression. She also has an outpatient clinic at the DCRP and often performs consultations for patients with Treatment-Resistant Depression. She has expertise in ketamine, VNS and DBS. Finally, she is one of the clinicians in the ECT team at MGH and she is involved in numerous research studies on ketamine in treatment-resistant mood disorders at MGH and is an Associate Professor in Psychiatry at Harvard Medical School.

Lauren B. Fisher, PhD is an Assistant Professor in Psychiatry at Harvard Medical School (HMS) and a Psychologist at the Massachusetts General Hospital. She is Director of Clinical Services at the MGH Depression Clinical and Research Program. She is currently the Principal Investigator of a K23 Mentored-Patient Oriented Research Career Development Award from the National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute for Child Health & Human Development (NICHD), evaluating a cognitive behavioral treatment for depression that has been adapted for individuals with moderate to severe traumatic brain injury.

Franklin King, MD is in Instructor, Harvard Medical School and the Director of Training and Education, Center for Neuroscience of Psychedelics
Massachusetts General Hospital

Michael Dean Kritzer-Cheren, MD, PhD is an attending for the TMS Service and Neuropsychiatry Clinics at Massachusetts General Hospital

Ananda Pandurangi, MD, is Director of the Schizophrenia Program and Brain Stimulation Therapy Program, Chairman and Medical Director, Division of Inpatient Psychiatry, and Vice Chair at the Department of Psychiatry at VCU. He received the MBBS degree from JIPMER, Pondicherry, India (1975) and an MD degree in Psychological Medicine (Bangalore University, India, 1978).

Planners

David Rubin, MD

Jane Pimental, MPH

Content Reviewers

Elizabeth Cox, RN

Sharon Fawcett, LICSW

Susan Kim, MD

Susan Sprich, PhD

Financial Disclosures:

Dr. Mischoulon is a Clinical Investigator and donated materials to Nordic Naturals and heckel medizintechnik GmbH and is a Clinical Rater and Director of Education for the MGH Clinical Trials Network and Institute (CTNI) and has received speaker honoraria from Peerpoint Medical Education.

Dr. Chopra receives speaker honoraria for the Psychopharmacology Institute and book royalties from Oxford University Press,

Dr. Camprodon is on the Scientific Advisory Board  for Flow Neuroscience, Hyka and a Consultant for Neuroelectrics, Mifu Technologies and LivaNova.

Dr. Cusin is a consultant for Clexio, Janssen, Compass Pathways and receives research funding from Livanova, Atai, NIMH, AFSP.

Dr. King is on the Scientific Advisory Board of Apex Labs and owns stock in Cybin and Compass Pathways.

Susan Sprich, PhD (Psychologist Reviewer) receives royalties: Oxford University Press; Springer and honorarium for associate editor of a journal: Association for Behavioral and Cognitive Therapies